Health News Archive - April 04, 2009
Workflow-driven solution helps providers streamline revenue cycle management, maximize revenue realization, and supports provider initiatives to enhance the patient experience CHICAGO, April 4 /PRNewswire-FirstCall/ -- Siemens (www.siemens.com/healthcare) today announced enhancements to its Soarian Revenue Cycle Management enterprise-wide solution at the Healthcare Information and Management Systems Society (HIMSS) 2009 Annual Conference and Exhibition in Chicago.
WALTHAM, Mass., April 4 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc.
Physicians can dramatically reduce the radiation dose delivered to patients undergoing coronary CT angiography in a â€œtriple rule-outâ€ protocol by simply using tube current modulation, according to a study performed at Thomas Jefferson University Hospital in Philadelphia, PA.
Radiologists can now lower the radiation dose delivered by cardiac CT angiography by 39% in adult patients weighing 185 pounds or less, according to a study performed at the University of Erlangen in Erlangen, Germany.
Researchers are one step closer to understanding the neurobiology that allows people to successfully learn motivated behaviors by associating environmental cues with rewarding outcomes, according to a study published yesterday in the Proceedings of the National Academy of Sciences' online Early Edition. Carlos Paladini
Scientists at the Centers for Disease Control and Prevention have discovered the presence of percholrate â€“ a chemical used in rocket fuel and also linked to thyroid disease - in 15 different types of baby formulas.
A team of researchers from the Massachusetts General Hospital Center for Engineering in Medicine (MGH-CEM) has found the first evidence of cell-to-cell communication by amino acids, the building blocks of proteins, rather than by known protein signaling agents such as growth factors or cytokines.
Radiologists have developed a computer based model that aids them in discriminating between benign and malignant breast lesions, according to a study performed at the University Of Wisconsin School of Medicine
Duke University researchers have identified a receptor on the surface of cells that may give them another avenue of attack against glioblastoma, the most common and most deadly type of brain cancer.
A collaboration of University of Pennsylvania and University of Wisconsin chemists and anesthesiologists have identified a fluorescent anesthetic compound that will assist researchers in obtaining more precise information about how anesthetics work in the body and will provide a means to more rapidly test new anesthetic compounds in the search for safer and more effective drugs.